NEW YORK (GenomeWeb) – Foundation Medicine said today that it would share data from 18,000 of its cases stored in its FoundationCORE database with the National Cancer Institute's Genomic Data Commons (GDC) database.
The data will be de-identified and HIPPA-compliant and will more than double the size of the current GDC database, which was launched earlier this month as part of Vice President Biden's Cancer Moonshot program and President Obama's Precision Medicine Initiative.
"This major infusion of data in the GDC will greatly enhance our ability to use this tool to explore genetic abnormalities in cancer," Douglas Low, acting director of the NCI, said in a statement.
"The insights gleaned from this data release will be instrumental in accelerating research and development efforts for targeted agents and immunotherapies," Vincent Miller, chief medical officer of Foundation Medicine, said in the release.
The FoundationCORE database currently contains genomic information from over 80,000 clinical cases. In February, the company made available data from pediatric cancer cases in support of the Precision Medicine Initiative.